Skip to content

Clinical trials

Observational Demyelinating Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Phase: Observational Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20091
20102
20111
20141
20151
20161
20181
20191
20202
20212
20223
20231
20245
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Not yet recruiting5
Recruiting5
Terminated3
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)2
Assiut University1
Association de Recherche Bibliographique pour les Neurosciences1
Baylor Research Institute1
Dongzhimen Hospital, Beijing1
Dragonfly Research, LLC1
EMD Serono1
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1
Fondazione Italiana Sclerosi Multipla1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases30
Multiple Sclerosis16
Autoimmune Diseases6
Nervous System Diseases6
Immune System Diseases5
Neuromyelitis Optica5
Autoimmune Diseases of the Nervous System3
Brain Diseases3
Brain Diseases, Metabolic, Inborn3
Central Nervous System Diseases3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.